Skip to
  1. Homepage
  2. Research and trials
  3. Clinical trials
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

A randomized, placebo-controlled, double blind phase IIb study evaluating miglustat treatment in patients with Mucopolysaccharidosis type III (MPS III) or Sanfilippo syndrome - Terminated -

Type of clinical trial   Drug clinical trial
Recruiting project   No
Orpha number ORPHA87555
Status   Terminated trial
Geographic coverage National
Funding body(ies) -
Sponsor Hospices civils de lyon 

Download document

[fr] (pdf,19ko)

Principal investigator of clinical trial :  
Dr Nathalie GUFFON
Unité des maladies métaboliques - CERLYMM
Hôpital Femme Mère Enfant - Département de pédiatrie
CHU de Lyon HCL - GH Est
59 Boulevard Pinel
69677 BRON CEDEX
FRANCE
More information

Phone  : 33 (0)4 72 12 95 37
Fax  : 33 (0)4 27 85 67 67

Contact secretary  :
email


Sponsor of clinical trial :  
HOSPICES CIVILS DE LYON
Direction de la recherche clinique
CHU de Lyon HCL - Direction de la recherche clinique
3 Quai des Célestins BP 2251
69229 LYON CEDEX 2
FRANCE
More information

Phone  : 33 (0)4 72 11 52 13
Fax  : -

Website
Contact secretary  :
email

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.